Human Apolipoprotein C-III (Apo C3) Antibody Conjugated to Biotin

Product Description

Human Apolipoprotein C-III (Apo C3) Antibody Conjugated to Biotin
Catalog number: B2014636
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 ug
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: −20°C
Keywords: Human Apolipoprotein C-III (Apo C3) Monoclonal Antibody (Biotin Conjugate)
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Boĭko ER, Ovechkin AO, Kaneva AM, Potolitsyna NN, Boĭko SG. [Uric acid, apo-E and apo-C3 correlation in normo- and hyperlipidemia] Ter Arkh. 2007;79(12):51-4.
2: Bonnet E, Bernard J, Fauvel J, Massip P, Ruidavets JB, Perret B. Association of APOC3 polymorphisms with both dyslipidemia and lipoatrophy in HAART-receiving patients AIDS Res Hum Retroviruses. 2008 Feb;24(2):169-71.
3: Hubacek JA, Bohuslavova R, Skodova Z, Pitha J, Bobkova D, Poledne R. Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change Clin Chem Lab Med. 2007;45(3):316-20.
4: Baum L, Ng MC, So WY, Lam VK, Wang Y, Poon E, Tomlinson B, Cheng S, Lindpaintner K, Chan JC. Effect of hepatic lipase -514C->T polymorphism and its interactions with apolipoprotein C3 -482C->T and apolipoprotein E exon 4 polymorphisms on the risk of nephropathy in chinese type 2 diabetic patients Diabetes Care. 2005 Jul;28(7):1704-9.
5: Lantz M, Sjöstrand C, Kostulas K. Ischemic stroke and patent foramen ovale: risk factors and genetic profile J Stroke Cerebrovasc Dis. 2013 Aug;22(6):841-5.
6: Mar R, Pajukanta P, Allayee H, Groenendijk M, Dallinga-Thie G, Krauss RM, Sinsheimer JS, Cantor RM, de Bruin TW, Lusis AJ. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia Circ Res. 2004 Apr 16;94(7):993-9.
7: Liu HK, Li XF, Zhang SZ, Ren Y, Yong-Xin, Liu YQ, Wang CT, Chen X, Hu YM, Zhang L. Association of Sst I polymorphism in apolipoprotein C3 gene with hypertriglyceridaemia in coronary atherosclerotic heart disease and type II diabetes mellitus in Chinese population Yi Chuan Xue Bao. 2005 Jan;32(1):11-8.
8: Shanker J, Perumal G, Rao VS, Khadrinarasimhiah NB, John S, Hebbagodi S, Mukherjee M, Kakkar VV. Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease Lipids Health Dis. 2008 Sep 19;7:33.
9: Hubacek JA, Waterworth DM, Poledne R, Pitha J, Skodová Z, Humphries SE, Talmud PJ. Genetic determination of plasma lipids and insulin in the Czech population Clin Biochem. 2001 Mar;34(2):113-8.
10: Sijbrands EJ, Hoffer MJ, Meinders AE, Havekes LM, Frants RR, Smelt AH, De Knijff P. Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2722-9.

Products Related to Human Apolipoprotein C-III (Apo C3) Antibody Conjugated to Biotin can be found at Conjugates